Analysts lift targets as DRI shorts rebuild ahead of earnings

Darden Restaurants heads into its September 23 earnings report with a rare combination: Wall Street lifting price targets into the print while short sellers quietly build positions and the stock slides 7% in a month.

The analyst picture is unambiguously bullish in direction, even as the stock retreats. Morgan Stanley raised its target to $255 from $236 this week, maintaining Overweight. Oppenheimer followed with a lift to $245 from $235. Seaport Global initiated at Buy with a $240 target. Citigroup had already moved to $248 the week prior. The Street consensus sits at Buy, with a mean target of $232.96 — roughly 11% above Monday's close of $209.12. Every recent move has been upward on the target, and the bull case rests on Darden's durable market-share gains across Olive Garden and LongHorn, its pricing discipline, and its status as the largest full-service dining operator globally. The bear case centres on macro fragility — consumer spending durability at mid-price occasions, food and labour inflation, and integration drag from Ruth's Chris and Chuy's — with the one neutral voice, Stephens, carrying a $220 target that implies limited upside from current levels.

Short interest is the contrarian signal worth watching. Bears have added exposure through the month: SI has risen 17.7% over the past 30 days to 5.88% of free float, with an 8.1% build just in the past week. That is a meaningful acceleration, not noise. The borrow market does not support a squeeze narrative — availability is comfortable at 974%, meaning roughly nine shares remain available for every one currently borrowed. Cost to borrow is negligible at 0.45%, barely changed on the week. So the short build is a deliberate directional bet, not a forced technical position. The ORTEX short score of 47.2 is middling — elevated enough to flag but not extreme — and has drifted up from 45.6 two weeks ago, tracking the SI increase.

Options positioning adds a further layer of caution. The put/call ratio is running modestly above its recent average at 0.88, about 0.8 standard deviations above the 20-day mean of 0.82. That is not a dramatic defensive spike, but the direction of travel matters: the ratio has been creeping higher since late August, when it was as low as 0.65. The 52-week high on PCR sits at 1.41, so there is material room for hedging demand to intensify before the earnings date. Taken together, the positioning story is one of gradual caution being layered in, not a crowded short or a panic.

The sector is under broad pressure this week. Close peers CAKE fell 9.8% on the week and DIN dropped 12.2%. BLMN lost 16.4% and CAVA 16.9%. Against that backdrop, Darden's 1.8% weekly decline looks like relative resilience, though its 4.3% single-day drop on Tuesday suggests it is not immune. MCD held up best of the group, down just 1.2% on the week — a reminder that the most defensive names in the space are attracting the least selling pressure. Factor positioning at Darden is mixed: the analyst recommendation rank scores at the 94th percentile, and dividend quality at 92nd, but EPS momentum is soft (37th percentile on the 90-day measure) and the value factor scores at just the 34th percentile on EV/EBIT.

Insider activity over the past 90 days skews negative. The CFO sold $1.78 million of stock on July 29. The Olive Garden president sold $1.85 million across two transactions on August 5 — the larger block paired with an option exercise, suggesting compensation mechanics, but the open-market component is a genuine sale at around $208. The LongHorn president sold roughly $318,000 at end of July. Net insider activity totals approximately -$13.5 million over the 90-day window. None of the trades were declared under a 10b5-1 plan. That is a notable one-directional signal from management, even if no single trade is alarming in isolation. Wellington Management is also worth noting on the institutional side: it has trimmed its stake from 6.0% to 3.4%, as disclosed in its August 13 filing — a meaningful reduction from one of the larger fundamental holders.

The one-day reaction to the last two earnings prints was flat to slightly positive (+0.1% and +0.3%), but both saw the stock drift lower over the following five days — the most recent quarter ending June 25 saw a five-day move of -4.3%. With the September 23 report a week away, the question for the next session is whether the analyst target-raise cycle provides enough support to hold the stock near $209, or whether the insider selling trend, rising short interest, and sector-wide pressure tighten the gap between where the stock trades and where the Street's caution begins.